SCHEMBL4773464

SCHEMBL4773464

OC(CNc1cc(-c2cccnc2)nc(-c2ccccn2)n1)COc1ccc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.42
RAB9A P51151 3/20 0.41
POLB P06746 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
MAPT P10636 2/20 0.40
CYP2A6 P11509 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
ROS1 P08922 2/20 0.40
NPC1 O15118 2/20 0.40
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC2A1 P11166 1/20 0.39
PTGDR Q13258 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771477 0.79 CYP2D6 (0.46) RAB9ACYP3A4CYP2C9CYP2A6ALDH1A1
SCHEMBL2241722 0.79 CYP2A6 (0.46) RAB9APOLBCYP3A4CYP2C9CYP2A6
SCHEMBL4771751 0.79 CYP2D6 (0.45) RAB9ACYP3A4CYP2C9CYP2A6ALDH1A1
SCHEMBL2235864 0.77 CYP2D6 (0.44) RAB9ACYP3A4CYP2C9CYP2A6ALDH1A1
SCHEMBL2238846 0.76 CYP3A4 (0.47) RAB9ACYP3A4CYP2C9CYP2A6ALDH1A1
SCHEMBL2241801 0.74 CLK4 (0.66) CYP3A4CYP2C9ALDH1A1LMNAHTT
SCHEMBL4775842 0.73 CYP3A4 (0.60) CYP3A4CYP2C9CYP2A6ALDH1A1LMNA
SCHEMBL4771527 0.73 CYP3A4 (0.55) RAB9ACYP3A4CYP2C9CYP2A6ALDH1A1
SCHEMBL2239929 0.73 CYP3A4 (0.65) CYP3A4CYP2C9CYP2A6ALDH1A1LMNA
SCHEMBL4771524 0.73 NPC1 (0.47) RAB9ACYP3A4CYP2C9MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed